title: [Strategies around PD-L1 testing in France].
authors.affiliation: Centre Jean-Perrin, Inserm UMR 1240, 58, rue Montalembert, 63011 Clermont-Ferrand, France. Electronic address: frederique.penault-llorca@clermont.unicancer.fr.
authors.forename: Frédérique
authors.initials: F
authors.lastname: Penault-Llorca
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000032:analysis* / Q000276:immunology; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000276:immunology; D005602:France; D006801:Humans; D007167:Immunotherapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D058990:Molecular Targeted Therapy; D009363:Neoplasm Proteins / Q000032:analysis* / Q000276:immunology; D009369:Neoplasms / Q000737:chemistry* / Q000276:immunology / Q000628:therapy; D011785:Quality Assurance, Health Care
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; D060890:B7-H1 Antigen; D014408:Biomarkers, Tumor; C423236:CD274 protein, human; D009363:Neoplasm Proteins; C582435:pembrolizumab